|
Treatment for organ rejection and autoimmune diseases
Drug carrier
Abstract
USC researchers have developed a novel strategy to carry CsA by binding it to its cognate receptor, cyclophilin. Significantly improved pharmacokinetic (PK) profile and therefore reduced systemic side effect were achieved by fusing cyclophilin with different types of elastin-like...
|